Diagnostics based on mAbs are critically important in healthcare. The AcPET system can rapidly make recombinant proteins as well as antibodies that compete in this arena. Diagnostics are currently used to identify viral, parasitic and bacterial pathogens, monitor drug safety profiles, and monitor the course of treatment. They are also used for imaging drug delivery and the response to the treatment. Diagnostics apply to veterinary as well as human applications. The global market for diagnostic mAbs was valued at USD 16.57 billion in 2016 and is projected to be valued at USD 21.21 billion in 2025 (Market Estimated and Trend Analysis Biologics Market, Grand View Research Inc., USA, Copyright 2017, page 77 ).
Diagnostics
The AcPET system can make recombinant proteins as well as antibodies that compete in this arena. Diagnostics are used to identify viral, parasitic and bacterial pathogens, monitor drug safety profiles and monitor the course of treatment.